Evidence map›Paper›PMID 42505264›Full record

ArticleGels (Basel, Switzerland)2026

Bioadhesive Alginate/Chitosan Hydrogels for Sustained Probiotic Delivery and Enhanced Antibacterial Treatment of Oral Ulcers.

Zhixiong Yu, Wenlin Qin, Xuanhe Fu, Kebin Xu, Xin Huang, Jinfeng He, Xin Li

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhixiong YuShenyang Key Laboratory of Prevention and Treatment of Systemic Important Diseases Associated with Oral Diseases, Shenyang 110034, China.
Wenlin QinShenyang Key Laboratory of Prevention and Treatment of Systemic Important Diseases Associated with Oral Diseases, Shenyang 110034, China.
Xuanhe FuShenyang Key Laboratory of Prevention and Treatment of Systemic Important Diseases Associated with Oral Diseases, Shenyang 110034, China.
Kebin XuShenyang Key Laboratory of Prevention and Treatment of Systemic Important Diseases Associated with Oral Diseases, Shenyang 110034, China.
Xin HuangShenyang Key Laboratory of Prevention and Treatment of Systemic Important Diseases Associated with Oral Diseases, Shenyang 110034, China.
Jinfeng HeShenyang Key Laboratory of Prevention and Treatment of Systemic Important Diseases Associated with Oral Diseases, Shenyang 110034, China.
Xin LiShenyang Key Laboratory of Prevention and Treatment of Systemic Important Diseases Associated with Oral Diseases, Shenyang 110034, China.

Funding

International Industrial Technology Research and Development Project of Liaoning Provincial Department of Science and Technology 2025JH2/101900023Liaoning Province Science and Technology Plan Joint Program 2024-BSLH-296Liaoning Provincial Belt and Road Joint Laboratory for China-Pakistan Human Phenomics Research 2026040003-JH6/1013Liaoning Provincial Department of Education LJ222410164024; LJ222410164030Liaoning Provincial Natural Science Foundation 2025-BS-0866
6 · The paper itself

Abstract

Recurrent aphthous ulcers (RAU) are highly prevalent oral mucosal lesions, while current therapies are limited by short residence time and poor efficacy in the dynamic oral environment. Probiotics such as

Indexed as

chitosanhydrogelprobioticrecurrent aphthous ulcersodium alginate

Identifiers

PMID42505264
PMCPMC13407556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.